MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Horizon Pharma PLC Company Profile (NASDAQ:HZNP)

Consensus Ratings for Horizon Pharma PLC (NASDAQ:HZNP) (?)
Ratings Breakdown: 10 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $37.11 (27.97% upside)

Current Analysts' Coverage Summary for Horizon Pharma PLC (NASDAQ:HZNP)
Show:
DateFirmActionRatingPrice TargetActions
8/10/2015Brean CapitalReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/3/2015GuggenheimReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015Piper JaffrayReiterated RatingOverweight$38.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015Leerink SwannReiterated RatingPositive$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/11/2015Morgan StanleyInitiated CoverageOverweight$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Jefferies GroupInitiated CoverageBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2015Stifel NicolausBoost Price TargetBuy$30.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015JMP SecuritiesBoost Price TargetMarket Outperform$25.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Citigroup Inc.Reiterated RatingBuy$19.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014Avondale PartnersInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2014Cowen and CompanyBoost Price Target$15.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2014R. F. LaffertyBoost Price TargetBuy$11.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha